Health Care & Life Sciences » Biotechnology | Infinity Pharmaceuticals Inc.

Infinity Pharmaceuticals Inc. | Mutual Funds

Mutual Funds that own Infinity Pharmaceuticals Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Vanguard Total Stock Market Index Fund
1,298,402
2.27%
0
0%
07/31/2018
Vanguard Extended Market Index Fund
724,616
1.27%
0
0%
07/31/2018
Biotech Growth Trust Plc (The)
433,767
0.76%
-203,459
0.14%
09/30/2017
Bridgeway Ultra Small Company Market Fund
350,000
0.62%
0
0.18%
12/31/2017
Wasatch Ultra Growth Fund
282,361
0.5%
282,361
0.34%
03/31/2018
Fidelity Spartan Extended Market Index Fund
236,483
0.42%
0
0%
07/31/2018
FCP OP Medical [email protected]
204,286
0.36%
23,000
0.26%
11/30/2017
DFA US Small Cap Portfolio
180,437
0.32%
95,077
0%
04/30/2018
British Columbia Inv Management Corp.
163,190
0.28%
163,190
0%
03/31/2017
DFA US Core Equity 2 Portfolio
127,833
0.23%
0
0%
04/30/2018

About Infinity Pharmaceuticals

View Profile
Address
784 Memorial Drive
Cambridge Massachusetts 02139
United States
Employees -
Website http://www.infi.com
Updated 07/08/2019
Infinity Pharmaceuticals, Inc. operates as a biopharmaceutical company, which engages in discovering, developing and delivering medicines for people with cancer. The company was founded by Steven H. Holtzman on March 22, 1995 and is headquartered in Cambridge, MA.